healthcarenpharma

North America continues to dominate the Human Biobanking Equipment Market owing to the strong presence of advanced healthcare infrastructure, extensive genomic research programs, and increasing investments in biobanking facilities. The region benefits from widespread adoption of automated storage systems, cryogenic equipment, and sample management technologies. Growing collaborations between research institutions, pharmaceutical companies, and government agencies are further strengthening market expansion across North America.

According to The Insight Partners, the Human Biobanking Equipment Market is expected to grow from US$ 1.46 billion in 2025 to US$ 1.85 billion by 2034, registering a CAGR of 2.65% during 2026–2034. The market is witnessing steady growth due to the increasing importance of biological sample preservation in medical research, drug development, regenerative medicine, and personalized healthcare. Biobanking equipment plays a critical role in maintaining the integrity, quality, and viability of biological specimens, including blood, tissues, DNA, RNA, stem cells, and other biospecimens.

The growing prevalence of chronic…

North America holds a significant share of the 3D hip and knee implant market, supported by advanced healthcare infrastructure, increasing adoption of additive manufacturing technologies, and a rising prevalence of orthopedic disorders. The region continues to witness strong demand for personalized implant solutions, particularly among the aging population. Growing investments in medical innovation and favorable reimbursement frameworks further contribute to market expansion across North America.

According to The Insight Partners, the 3D Hip and Knee Implant Market size is expected to reach US$ 24.96 billion by 2034 from US$ 6.96 billion in 2025. The market is estimated to record a robust CAGR of 17.31% from 2026 to 2034. The remarkable growth trajectory reflects the increasing integration of 3D printing technologies in orthopedic implant manufacturing, enabling customized solutions that improve patient outcomes and surgical precision.  

The healthcare industry has witnessed significant transformation with the adoption of additive manufacturing techniques. In orthopedic applications,…

North America continues to hold a significant share of the Infant Incubator Market due to its advanced neonatal healthcare infrastructure, increasing investments in neonatal intensive care units (NICUs), and widespread adoption of technologically advanced infant care equipment. The region also benefits from favorable reimbursement policies and growing awareness regarding neonatal health and premature birth management.

Infant Incubator Market Overview

According to The Insight Partners, the Infant Incubator Market size is expected to reach US$ 4.29 Billion by 2034 from US$ 2.31 Billion in 2025. The market is estimated to record a CAGR of 7.13% from 2026 to 2034.

Infant incubators are specialized medical devices designed to provide a controlled environment for newborn babies, particularly premature infants and those with critical health conditions. These devices help maintain optimal temperature, humidity, and oxygen levels while protecting infants from infections and environmental stressors. As neonatal healthcare continues to advance globally, the demand for sophisticated infant…

The remotely medical treatment device market in North America continues to dominate the global landscape due to advanced healthcare infrastructure, widespread adoption of telemedicine technologies, and increasing investments in digital health solutions. The region benefits from strong government support, favorable reimbursement policies, and growing demand for remote patient monitoring systems among aging populations and patients with chronic diseases.

According to The Insight Partners, the Remotely Medical Treatment Device Market is expected to grow significantly over the forecast period. The market size is projected to reach US$ 33.88 billion by 2034, up from US$ 16.12 billion in 2025, registering a robust CAGR of 8.60% from 2026 to 2034. The increasing integration of digital technologies in healthcare, rising demand for remote patient care, and expanding telehealth services are among the primary factors driving market expansion worldwide.

Remotely medical treatment devices have emerged as essential tools in modern healthcare systems. These devices enable healthcare providers…